Biotransformation Pathways and Metabolite Profiles of Oral [14C]Alisertib (MLN8237), an Investigational Aurora A Kinase Inhibitor, in Patients with Advanced Solid TumorsSandeepraj Pusalkar, Swapan K. Chowdhury|Drug Metabolism and Disposition|2020Cited by 16